Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine

(2022) Francisco Tsz Tsun Lai et al.   ANNALS OF INTERNAL MEDICINE

Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China

(2022) Min Kang et al.   ANNALS OF INTERNAL MEDICINE

Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study

(2022) Xue Li et al.   GUT

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

(2022) Emma K. Accorsi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection

(2022) Francisco Tsz Tsun Lai et al.   JOURNAL OF INTERNAL MEDICINE

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

(2022) Samuel MS Cheng et al.   Eurosurveillance

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

(2022) Thiago Cerqueira-Silva et al.   LANCET INFECTIOUS DISEASES

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

(2022) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

BNT162b2 Protection against the Omicron Variant in Children and Adolescents

(2022) Ashley M. Price et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study

(2022) Xi Xiong et al.   THYROID

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

(2022) Adam S Lauring et al.   BMJ-British Medical Journal

Covid-19: Hong Kong reports world’s highest death rate as zero covid strategy fails

(2022) Luke Taylor   BMJ-British Medical Journal

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong

(2022) Qiaoli Peng et al.   EBioMedicine

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy

(2022) Zsolt Matula et al.   Vaccines

Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody

(2022) Kristi Tsz-Wan Lai et al.   Vaccines

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

(2021) Mark G. Thompson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

(2021) Mine Durusu Tanriover et al.   LANCET

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

(2021) Alejandro Jara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

(2021) Robert W. Frenck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

(2021) Mark G. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19

(2021) Wey Wen Lim et al.   Lancet Microbe

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong

(2021) Xue Li et al.   ANNALS OF THE RHEUMATIC DISEASES

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination

(2021) Gilbert T Chua et al.   CLINICAL INFECTIOUS DISEASES

Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark

(2021) Kimihito Ito et al.   JOURNAL OF MEDICAL VIROLOGY

China’s COVID vaccines have been crucial — now immunity is waning

(2021) Smriti Mallapaty   NATURE

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

(2021) Ital Nemet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

(2021) Hiam Chemaitelly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

(2021) István Vályi-Nagy et al.   GeroScience

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

(2020) Carolyn Rydyznski Moderbacher et al.   CELL

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE